Cost-effectiveness of integrating gut microbiota analysis into hospitalisation prediction in cirrhosis.
Jasmohan Singh BajajChathur AcharyaMasoumeh SikaroodiPatrick M GillevetLeroy R ThackerPublished in: GastroHep (2020)
Gut microbiota analysis is cost-effective for predicting and potentially preventing 90-day admissions in cirrhosis over current standard of care. This cost-saving remained robust even after sensitivity analyses that varied the background admission rates.